BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30416066)

  • 1. Evaluation of a pharmacist-physician covisit model in a family medicine practice.
    Ulrich IP; Patel S; Gilmer B
    J Am Pharm Assoc (2003); 2019; 59(1):129-135. PubMed ID: 30416066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to clinical pharmacy services in a pharmacist-physician covisit model.
    Ulrich IP; Lugo B; Hughes P; Doucette L; Creith BB; Flanagan S; Gilmer B
    Res Social Adm Pharm; 2021 Jul; 17(7):1321-1326. PubMed ID: 33153913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
    Wilson CG; Park I; Sutherland SE; Ray L
    J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design and evaluation of a pilot covisit model: Integration of a pharmacist into a primary care team.
    Roll A; Pattison D; Baumgartner R; Sublett L; Brown B
    J Am Pharm Assoc (2003); 2020; 60(3):491-496. PubMed ID: 31889652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office.
    Thomas MH; Goode JV
    J Am Pharm Assoc (2003); 2014; 54(4):427-34. PubMed ID: 25063263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sustainable business model for comprehensive medication management in a patient-centered medical home.
    Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
    J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and implementation of ambulatory care pharmacy services at an internal medicine clinic.
    Wells C; Warren AC; Ashe Scott M
    Am J Health Syst Pharm; 2024 Apr; ():. PubMed ID: 38613410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of a primary care pharmacist practice-based research network.
    Dickerson LM; Kraus C; Kuo GM; Weber CA; Bazaldua OV; Tovar JM; Hume AL; Ives TJ; Gums JG; Carter BL
    Am J Health Syst Pharm; 2007 Oct; 64(19):2044-9. PubMed ID: 17893415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report on financing the new model of family medicine.
    Spann SJ;
    Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate.
    Arnold ME; Buys L; Fullas F
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S36-42. PubMed ID: 25991594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
    Wong SL; Barner JC; Sucic K; Nguyen M; Rascati KL
    J Am Pharm Assoc (2003); 2017; 57(3):375-381. PubMed ID: 28506398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacy's journey toward the patient-centered medical home.
    Erickson S; Hambleton J
    J Am Pharm Assoc (2003); 2011; 51(2):156-60. PubMed ID: 21382804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of pharmacists into a patient-centered medical home.
    Scott MA; Hitch B; Ray L; Colvin G
    J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an ambulatory care pharmacist in an occupational health clinic.
    Parsons KA; Zimmermann AE
    J Am Pharm Assoc (2003); 2019; 59(1):64-69.e1. PubMed ID: 30396761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Economic Analysis of Pharmacist-Led Annual Wellness Visits.
    Mallouh MA; Briggs A; Hawkins S; Heffern C
    Sr Care Pharm; 2023 May; 38(5):185-192. PubMed ID: 37185146
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of the Primary Care Exception on Family Medicine Resident Coding.
    Cawse-Lucas J; Evans DV; Ruiz DR; Allcut EA; Andrilla CH; Thompson M; Norris TE
    Fam Med; 2016 Mar; 48(3):175-9. PubMed ID: 26950905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacist-provided Medicare annual wellness visits and chronic care management on reimbursement and quality measures in a privately owned family medicine clinic.
    Mack K; Henneman A; Snyder T
    Am J Health Syst Pharm; 2023 Nov; 80(Suppl 4):S143-S150. PubMed ID: 36860179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Physician-Pharmacist Covisits at a Primary Care Clinic in Patients With Uncontrolled Diabetes.
    Peterson J; Hinds A; Garza A; Barner J; Hill L; Nguyen M; Lai P; Gums T
    J Pharm Pract; 2020 Jun; 33(3):321-325. PubMed ID: 30428760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.